Zentalis Pharmaceuticals, Inc. (ZNTL) Tops Q4 EPS by 19c
Tweet
Share
E-mailGet Alerts ZNTL Hot Sheet
Join SI Premium – FREE
Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) reported Q4 EPS of ($0.87), $0.19 better than the analyst estimate of ($1.06).
For earnings history and earnings-related data on Zentalis Pharmaceuticals, Inc. (ZNTL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ciena beats estimates on strong AI-driven demand, shares rise
- Broadcom shares fall 3% after revenue forecast misses estimates
- Lands' End (LE) Tops Q2 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
